Nav: Home

UAEU licenses BioLegend (USA) to use 4 of its patents in order to diagnose Parkinson's disease

May 31, 2016

The United Arab Emirates University (UAEU) has signed a licensing agreement with USA-based global pharmaceutical company BioLegend, Inc. to use four different UAEU patents in biotechnology. The license was granted in order to develop diagnostic tools for the early detection of Parkinson's Disease and possibly other neurological diseases.

The technology was developed at UAEU and is patent protected in the USA, the European Union and other countries and regions worldwide. Dr. Ali Rashid Al Noaimi, Vice Chancellor of UAEU, signed the agreement on behalf of the university, while Dr. Gene Lay, the CEO and founder of BioLegend signed on behalf of the US company.

His Excellency Dr. Ali Rashid Al Nuaimi, Vice Chancellor of UAEU, stressed that this patent agreement was the second of its kind at UAEU. This is yet more evidence of the university's pursuit of excellence in order to follow the directives of the national leadership headed by His Highness Sheikh Khalifa Bin Zayed Al Nahyan, the President of UAE; and in accordance with the vision of His Highness Sheikh Mohammed Bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai. Such directives are further supported by His Highness General Sheikh Mohammed Bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Deputy Supreme Commander of the Armed Forces. This is also in tune with UAE Vision 2021. The Vice Chancellor added that UAEU reflects the leadership's focus on healthcare. Finally, he also added that, "the knowledge-based economy is part of the global economy and our national university should protect and market its technological discoveries and collaborate with industrial leaders globally and within the country."

Dr. Al Nuaimi also welcomed the announcement by saying that UAEU was honoured to cooperate with a global pharmaceutical company that specialized in brain diseases and neurological research as just such research is being carried out at the university. He also highlighted the importance of protecting research results by filing patent applications to protect the new discoveries: "UAEU has more than 80 different new inventions and around 190 patent applications in its portfolio, of which 36 have already been granted."

Dr. Gene Lay added that BioLegend were, "happy to have a partnership with United Arab Emirates University and is committed to the commercial development and exploitation of these patents." He further added that BioLegend was striving to provide quality research reagents and expert technical support to the worldwide scientific. Their mission is to accelerate research and discovery by providing the highest quality products at outstanding value, along with superior customer service and technical support.

Professor Ghaleb Al Hadrami, the Deputy Vice Chancellor for Research and Graduate Studies, said that the university supports scientific excellence and innovation and said that, "there were four international competitors negotiating for the license, however our office chose BioLegend due to their leading position in developing and manufacturing world-class, cutting-edge immunological reagents for biomedical research." He also noted the efforts of Mohamed Al Hemairy, Head of Patents and Technology Transfer at the university, and said that, "this deal took over a year of discussion before reaching a mutual consensus. Licensing biochemistry patents in the neurological sciences is challenging due to the complexity of the technology, as well as the time it requires to negotiate the details of the agreement especially when it involves human experimentation."

The driving force behind this technology is Professor Omar El-Agnaf and his team of experienced postdoctoral and postgraduate researchers in the College of Medicine and Health Sciences at UAEU. They developed assays for the detection of proteins involved in Parkinson's Disease. Between seven to ten million people worldwide live with Parkinson's Disease and the lack of early detection is recognised as an impediment to effective clinical intervention as well as retarding the development of new therapeutics.
-end-


United Arab Emirates University

Related Technology Articles:

How technology use affects at-risk adolescents
More use of technology led to increases in attention, behavior and self-regulation problems over time for adolescents already at risk for mental health issues, a new study from Duke University finds.
Hold-up in ventures for technology transfer
The transfer of technology brings ideas closer to commercialization. The transformation happens in several steps, such as invention, innovation, building prototypes, production, market introduction, market expansion, after sales services.
The ultimate green technology
Imagine patterning and visualizing silicon at the atomic level, something which, if done successfully, will revolutionize the quantum and classical computing industry.
New technology detects COPD in minutes
Pioneering research by Professor Paul Lewis of Swansea University's Medical School into one of the most common lung diseases in the UK, Chronic Obstructive Pulmonary Disease, has led to the development of a new technology that can quickly and easily diagnose and monitor the condition.
New technology for powder metallurgy
Tecnalia leads EFFIPRO (Energy EFFIcient PROcess of Engineering Materials) project, which shows a new manufacturing process using powder metallurgy.
New milestone in printed photovoltaic technology
A team of researchers at Friedrich-Alexander-Universität have achieved an important milestone in the quest to develop efficient solar technology as an alternative to fossil fuels.
Gene Drive Technology: Where is the future?
For this episode of BioScience Talks, we're joined by Gene Drive Committee co-chair James P.
Could Hollywood technology help your health?
The same technology used by the entertainment industry to animate characters such as Gollum in 'The Lord of The Rings' films, will be used to help train elite athletes, for medical diagnosis and even to help improve prosthetic limb development, in a new research center at the University of Bath launched today.
Assessing carbon capture technology
Carbon capture and storage could be used to mitigate greenhouse gas emissions and thus ameliorate their impact on climate change.
New technology for dynamic projection mapping
It has been thought technically difficult to achieve projection mapping onto a moving/rotating object so that images look as though they are fixed to the object.

Related Technology Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#529 Do You Really Want to Find Out Who's Your Daddy?
At least some of you by now have probably spit into a tube and mailed it off to find out who your closest relatives are, where you might be from, and what terrible diseases might await you. But what exactly did you find out? And what did you give away? In this live panel at Awesome Con we bring in science writer Tina Saey to talk about all her DNA testing, and bioethicist Debra Mathews, to determine whether Tina should have done it at all. Related links: What FamilyTreeDNA sharing genetic data with police means for you Crime solvers embraced...